ARCA Biopharma Inc (NASDAQ:ABIO)

1.65
Delayed Data
As of Feb 16
 +0.005 / +0.30%
Today’s Change
1.05
Today|||52-Week Range
2.76
+22.22%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$19.4M

Company Description

ARCA biopharma, Inc. is a biopharmaceutical company, which develops genetically targeted therapies for heart failure and other cardiovascular diseases. The company engages in cardiovascular pathophysiology, molecular genetics and clinical development. Its product candidate, GencaroTM is a pharmacologic beta-blocker and mild vasodilator, which is developed for the treatment of chronic heart failure and other indications. The company was founded by Michael R. Bristow and Christopher David Ozeroff in 1992 and is headquartered in Westminster, CO.

Contact Information

ARCA biopharma, Inc.
11080 CirclePoint Road
Westminster Colorado 80020
P:(720) 940-2100
Investor Relations:
(720) 940-2163

Employees

Shareholders

Mutual fund holders21.99%
Individual stakeholders14.52%
Other institutional12.74%

Top Executives

Michael R. BristowPresident, Chief Executive Officer & Director
Thomas A. KeuerChief Operating Officer
Brian L. SelbyChief Accounting Officer & Vice President-Finance
Christopher David OzeroffSecretary, Senior Vice President & General Counsel
Derek K. ColeInvestor Relations & Media Contact